BioNTech SE (BNTX)
86.16
-0.24
(-0.28%)
USD |
NASDAQ |
Apr 18, 16:00
85.47
-0.69
(-0.80%)
After-Hours: 05:07
BioNTech Profit Margin (Quarterly): 30.96% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.96% |
| September 30, 2023 | 17.94% |
| June 30, 2023 | -113.5% |
| March 31, 2023 | 39.33% |
| December 31, 2022 | 53.26% |
| September 30, 2022 | 51.57% |
| June 30, 2022 | 52.31% |
| March 31, 2022 | 58.02% |
| December 31, 2021 | 57.23% |
| September 30, 2021 | 52.75% |
| June 30, 2021 | 52.50% |
| Date | Value |
|---|---|
| March 31, 2021 | 55.07% |
| December 31, 2020 | |
| September 30, 2020 | -311.1% |
| June 30, 2020 | -211.8% |
| March 31, 2020 | -192.8% |
| December 31, 2019 | -208.1% |
| September 30, 2019 | -105.0% |
| June 30, 2019 | -194.2% |
| March 31, 2019 | -155.4% |
| December 31, 2018 | -2.12% |
| September 30, 2018 | -114.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-311.1%
Minimum
Sep 2020
58.02%
Maximum
Mar 2022
-45.31%
Average
35.14%
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | -23.64% |
| BioVie Inc | -- |
| Autolus Therapeutics PLC | -- |
| Moderna Inc | 7.71% |
| MorphoSys AG | 81.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.60% |
| Return on Assets | 4.09% |
| Return on Invested Capital | 4.55% |
| Gross Profit Margin (Quarterly) | 87.89% |
| Operating Margin (Quarterly) | 40.43% |
| Return on Net Operating Assets | 13.83% |